Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain
- Schmidt, R.
- Majer, I.
- García Román, N.
- Rivas Basterra, A.
- Grubb, E.B.
- Medrano López, C.
Revista:
Health Economics Review
ISSN: 2191-1991
Año de publicación: 2017
Volumen: 7
Número: 1
Tipo: Artículo
